Upgrade to SI Premium - Free Trial

Sagimet Biosciences Inc (SGMT) PT Raised to $28 at Oppenheimer

April 27, 2026 11:29 AM
Oppenheimer analyst Jay Olson raised the price target on Sagimet Biosciences Inc (NASDAQ: SGMT) to $28.00 (from $25.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change